FDA Approved: ZERVIATE — Supplemental Application (Harrow Eye, LLC)

View source ↗

Summary

The FDA approved a supplemental application for ZERVIATE (cetirizine) submitted by Harrow Eye, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• ZERVIATE (Cetirizine)

Snippet

SUPPL AP for ZERVIATE (CETIRIZINE)